Report Detail

Other Global Human Immunodeficiency Virus(HIV) Market Size, Status and Forecast 2019-2025

  • RnM3398207
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Human Immunodeficiency Virus(HIV) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Diagnosis
      • 1.4.3 Treatment
    • 1.5 Market by Application
      • 1.5.1 Global Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centers
      • 1.5.4 Diagnostic Centers
      • 1.5.5 Homecare Settings
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Human Immunodeficiency Virus(HIV) Market Size
    • 2.2 Human Immunodeficiency Virus(HIV) Growth Trends by Regions
      • 2.2.1 Human Immunodeficiency Virus(HIV) Market Size by Regions (2014-2025)
      • 2.2.2 Human Immunodeficiency Virus(HIV) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Human Immunodeficiency Virus(HIV) Market Size by Manufacturers
      • 3.1.1 Global Human Immunodeficiency Virus(HIV) Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Human Immunodeficiency Virus(HIV) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Human Immunodeficiency Virus(HIV) Key Players Head office and Area Served
    • 3.3 Key Players Human Immunodeficiency Virus(HIV) Product/Solution/Service
    • 3.4 Date of Enter into Human Immunodeficiency Virus(HIV) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019)
    • 4.2 Global Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Human Immunodeficiency Virus(HIV) Market Size (2014-2019)
    • 5.2 Human Immunodeficiency Virus(HIV) Key Players in United States
    • 5.3 United States Human Immunodeficiency Virus(HIV) Market Size by Type
    • 5.4 United States Human Immunodeficiency Virus(HIV) Market Size by Application

    6 Europe

    • 6.1 Europe Human Immunodeficiency Virus(HIV) Market Size (2014-2019)
    • 6.2 Human Immunodeficiency Virus(HIV) Key Players in Europe
    • 6.3 Europe Human Immunodeficiency Virus(HIV) Market Size by Type
    • 6.4 Europe Human Immunodeficiency Virus(HIV) Market Size by Application

    7 China

    • 7.1 China Human Immunodeficiency Virus(HIV) Market Size (2014-2019)
    • 7.2 Human Immunodeficiency Virus(HIV) Key Players in China
    • 7.3 China Human Immunodeficiency Virus(HIV) Market Size by Type
    • 7.4 China Human Immunodeficiency Virus(HIV) Market Size by Application

    8 Japan

    • 8.1 Japan Human Immunodeficiency Virus(HIV) Market Size (2014-2019)
    • 8.2 Human Immunodeficiency Virus(HIV) Key Players in Japan
    • 8.3 Japan Human Immunodeficiency Virus(HIV) Market Size by Type
    • 8.4 Japan Human Immunodeficiency Virus(HIV) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Human Immunodeficiency Virus(HIV) Market Size (2014-2019)
    • 9.2 Human Immunodeficiency Virus(HIV) Key Players in Southeast Asia
    • 9.3 Southeast Asia Human Immunodeficiency Virus(HIV) Market Size by Type
    • 9.4 Southeast Asia Human Immunodeficiency Virus(HIV) Market Size by Application

    10 India

    • 10.1 India Human Immunodeficiency Virus(HIV) Market Size (2014-2019)
    • 10.2 Human Immunodeficiency Virus(HIV) Key Players in India
    • 10.3 India Human Immunodeficiency Virus(HIV) Market Size by Type
    • 10.4 India Human Immunodeficiency Virus(HIV) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Human Immunodeficiency Virus(HIV) Market Size (2014-2019)
    • 11.2 Human Immunodeficiency Virus(HIV) Key Players in Central & South America
    • 11.3 Central & South America Human Immunodeficiency Virus(HIV) Market Size by Type
    • 11.4 Central & South America Human Immunodeficiency Virus(HIV) Market Size by Application

    12 International Players Profiles

    • 12.1 Gilead
      • 12.1.1 Gilead Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.1.4 Gilead Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.1.5 Gilead Recent Development
    • 12.2 GlaxoSmithKline
      • 12.2.1 GlaxoSmithKline Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.2.4 GlaxoSmithKline Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Recent Development
    • 12.3 Johnson & Johnson
      • 12.3.1 Johnson & Johnson Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.3.4 Johnson & Johnson Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.3.5 Johnson & Johnson Recent Development
    • 12.4 Merck
      • 12.4.1 Merck Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.4.4 Merck Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.4.5 Merck Recent Development
    • 12.5 AbbVie
      • 12.5.1 AbbVie Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.5.4 AbbVie Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.5.5 AbbVie Recent Development
    • 12.6 Bristol-Myers Squibb
      • 12.6.1 Bristol-Myers Squibb Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.6.4 Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.6.5 Bristol-Myers Squibb Recent Development
    • 12.7 Boehringer Ingelheim
      • 12.7.1 Boehringer Ingelheim Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.7.4 Boehringer Ingelheim Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.7.5 Boehringer Ingelheim Recent Development
    • 12.8 Genentech
      • 12.8.1 Genentech Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.8.4 Genentech Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.8.5 Genentech Recent Development
    • 12.9 Cipla
      • 12.9.1 Cipla Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Human Immunodeficiency Virus(HIV) Introduction
      • 12.9.4 Cipla Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)
      • 12.9.5 Cipla Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
      The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
      In 2018, the global Human Immunodeficiency Virus(HIV) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Human Immunodeficiency Virus(HIV) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Immunodeficiency Virus(HIV) development in United States, Europe and China.

      The key players covered in this study
      Gilead
      GlaxoSmithKline
      Johnson & Johnson
      Merck
      AbbVie
      Bristol-Myers Squibb
      Boehringer Ingelheim
      Genentech
      Cipla

      Market segment by Type, the product can be split into
      Diagnosis
      Treatment

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgical Centers
      Diagnostic Centers
      Homecare Settings
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Human Immunodeficiency Virus(HIV) status, future forecast, growth opportunity, key market and key players.
      To present the Human Immunodeficiency Virus(HIV) development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Human Immunodeficiency Virus(HIV) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Human Immunodeficiency Virus(HIV) . Industry analysis & Market Report on Human Immunodeficiency Virus(HIV) is a syndicated market report, published as Global Human Immunodeficiency Virus(HIV) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Human Immunodeficiency Virus(HIV) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,026.36
      4,539.54
      6,052.71
      3,501.44
      5,252.17
      7,002.89
      423,309.90
      634,964.85
      846,619.80
      277,407.78
      416,111.67
      554,815.56
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report